Path BioAnalytics
Chapel Hill
About Path BioAnalytics
Precision medicine–tailoring drug treatment to specific patient populations–holds enormous potential for the future of healthcare. Here at PBA, we are pursuing both precision development, the targeted development of new treatments for specific patient populations, and precision treatment, the selective use of existing medications based on an individual’s unique characteristics.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $100.0K
- Funding stage: Seed
- Last round: Pre-Seed (May 2020)
- Website: pathbioanalytics.com
- Phone: [email protected]
Industries & Categories
Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/path-bioanalytics-2234235 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.